Elinogrel clinical trials
Also written PRT060128.
Includes 1 study of Elinogrel potassium.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses elinogrel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Portola Pharmaceuticals (2) · Alexion Pharmaceuticals, Inc. (1)
Studies
Open first, then newest update. How each study uses elinogrel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMITerminatedPhase 2Alexion Pharmaceuticals, Inc.NCT00546260Written as PRT060128 Potassium
- A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCICompletedPhase 2Portola PharmaceuticalsNCT00751231Written as PRT060128
- Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal ImpairmentTerminatedPhase 1Portola PharmaceuticalsNCT00984113Written as Elinogrel
Codes
What other systems call elinogrel · ClinicalTrials.gg INT005628
- MeSH (NLM) C549473elinogrelOne source NLM
- UNII (FDA) 915Y8E749JELINOGRELConfirmed FDA, NLM, Wikidata
- Wikidata Q15408411elinogrelConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C96896ElinogrelOne source FDA
- DrugBank DB06350One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C549473 | elinogrel | One source NLM |
| UNII (FDA) | 915Y8E749J | ELINOGREL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15408411 | elinogrel | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C96896 | Elinogrel | One source FDA |
| DrugBank | DB06350 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.